Diclofenac Immediate-Release Tablets and Omalizumab Subcutaneous
Determining the interaction of Diclofenac Immediate-Release Tablets and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diclofenac
Brand name: Cambia, Cataflam, Voltaren-XR, Zipsor, Zorvolex, Voltaren, Dyloject, also Cambia
Synonyms: Diclofenac, Diclofenac (Systemic)
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diclofenac Immediate-Release Tablets-Ombitasvir, Paritaprevir, and Ritonavir
- Diclofenac Immediate-Release Tablets-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Diclofenac Immediate-Release Tablets-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Diclofenac Immediate-Release Tablets-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Diclofenac Immediate-Release Tablets-Omeclamox-Pak
- Diclofenac Immediate-Release Tablets-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Diclofenac Injection
- Omalizumab Subcutaneous-Diclofenac Intravenous
- Omalizumab Subcutaneous-Diclofenac ophthalmic
- Omalizumab Subcutaneous-Diclofenac Ophthalmic Solution
- Omalizumab Subcutaneous-Diclofenac Oral Solution
- Omalizumab Subcutaneous-Diclofenac Potassium